Skip to content

Apotheek Mouton

Active
Private limited companyfounded 2009active for 17 yearsWeststraat 34, 9940 Evergem, BelgiumKBO/BCE: BE 0818.054.943

From the official registers: KBO 16 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Apotheek Mouton has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €733,698 and a net result of €169,296. Equity is growing by about 21% per year across the filed financial years. Its solvency ranks better than 84% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 26-08-2009 Normal situation
Legal form
Private limited company
Registered office
Weststraat 34, 9940 Evergem
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment unit
2.180.741.825 9940 Evergem, since 01-10-2009
Financial year end
31 December
Peppol
Reachable since 27-10-2025

Who decides

Board
  • MIRREDirector · since 28-02-2026 · permanent representative Hilde Mouton

How it is doing

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€397,175
▼ 17.1%
Turnover
≈ €1.4m
estimated
Profit
€169,296
▼ 17.3%
Equity
€733,698
▲ 30.0%
Total assets
€999,574
▲ 21.2%
Staff
2.6 FTE
▼ 16.1%
2025 accounts 32 days early
Filed on 29-06-2026at the National Bank
Why 98lowers riskLiquidity: current ratio 6.09, cash €397,049Equity €733,698 (73.4% of total assets)Founded in 2009Figures for financial year 2025 (filed 29-06-2026)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 86% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 98+5
equity 73.4% of total assets
Liquidity 96+1
short-term debt 15.8% · cash 39.7%
Profitability 90-10
return on assets 16.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €70,000 on 30-day terms is acceptable
Liquidity ample (current ratio 6.09, compared with 5.16 in 2024, above the usual 1.5; short-term debt: 15.8% and cash: 39.7% of total assets), and 26.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 83% on solvency, 95% on liquidity, 85% on profitability and 79% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 6.09, cash €397,049
NBB · annual accounts
lowers risk · Equity €733,698 (73.4% of total assets)
NBB · annual accounts
lowers risk · Founded in 2009
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Figures for financial year 2025 (filed 29-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
32 days early
2024
17 days early
2023
20 days early
2022
21 days late
2021
16 days early
2020
15 days early
2019
21 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 14 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Caution: Board changedlatest change 01-03-2026 · 1 in office 1 joined · 2 left View
  • Positive: Among the best 15% on net resultsector median €27,659 · 12,727 companies €169,296 View
  • Positive: 8 profitable years in a rowprofit 2025: €169,296 8 years View
  • 2 restructurings since 2024latest: merger with MM PHARMINVEST 2 View
  • Positive: Equity rose in 2025from €564,402 to €733,698 ▲ 30.0% View

Documents

Key facts about Apotheek Mouton

What is the company number of Apotheek Mouton?
0818.054.943. In Belgium the VAT number is the company number with BE in front: BE 0818.054.943.
Where is Apotheek Mouton based?
The registered office is at Weststraat 34, 9940 Evergem.Company details
What does Apotheek Mouton do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Mouton?
Private limited company (BV).
When was Apotheek Mouton founded?
On 26-08-2009.
Is Apotheek Mouton still active?
Yes, Apotheek Mouton is an active enterprise in the KBO register.
How many employees does Apotheek Mouton have?
On average 2.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Apotheek Mouton?
≈ €1.4m in financial year 2025. Estimated from the gross margin of €397,175: probably between €1.1m and €2.4m, based on 47 comparable companies, NACE 477.
Is Apotheek Mouton profitable?
In financial year 2025, Apotheek Mouton made a profit of €169,296.
Where can I find the annual accounts of Apotheek Mouton?
Apotheek Mouton filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Apotheek Mouton due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Apotheek Mouton

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.